2m 2m 2m 2m 2m 2m 2m
BioNTech Sp ADR (BNTX)
NASDAQ
$89.69-$0.50 (-0.56%)
Price as of Jun 23, 2026 7:54 PM EDT- $22.8BMarket Cap
- -12.45%1-Year Change
- BiotechnologyIndustry
BioNTech Sp ADR (BNTX)
$89.69-$0.50 (-0.56%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 60.0M -97.82% | 2.8B -27.96% | 3.8B -77.94% | 17.3B -8.78% | |
Cost of Revenue | 641.8M +18.57% | 541.3M -9.75% | 599.8M -79.97% | 3.0B +2.87% | |
Gross Profit | -581.8M -126.33% | 2.2B -31.36% | 3.2B -77.51% | 14.3B -10.89% | |
Sales and Marketing Expense | 110.0M +62.00% | 67.9M +8.29% | 62.7M +5.38% | 59.5M +18.06% | |
Research and Development Expense | -2.1B -6.62% | -2.3B +26.42% | -1.8B +16.01% | -1.5B +61.93% | |
Depreciation and Amortization Expense | 382.8M +28.46% | 298.0M +62.49% | 183.4M +48.74% | 123.3M +63.96% | |
Total Operating Expenses | 514.4M -3.14% | 531.1M +6,622.78% | 7.9M -98.37% | 484.7M +69.59% | |
Operating Profit | -1.4B +6.89% | -1.3B -290.37% | 690.4M -94.54% | 12.6B -17.28% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -14.2M N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | -14.2M N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 14.2M N/A | N/A N/A | N/A N/A | N/A N/A | |
Income before Taxes | -1.1B +70.77% | -665.3M -171.51% | 930.3M -90.14% | 9.4B -8.34% | |
Income Taxes | 85.3M +787.90% | -12.4M -104.85% | 255.8M -92.73% | 3.5B -25.96% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -1.1B +70.77% | -665.3M -171.51% | 930.3M -90.14% | 9.4B -8.34% | |
Net Income from Continuing Operations Applicable to Common | -1.1B +70.77% | -665.3M -171.51% | 930.3M -90.14% | 9.4B -8.34% | |
Basic EPS and Net Income | -4.70 +69.68% | -2.77 -171.58% | 3.87 -90.02% | 38.78 -8.06% | |
Diluted EPS and Net Income | -4.70 +69.68% | -2.77 -172.32% | 3.83 -89.86% | 37.77 -4.69% | |
Basic Weighted Average Shares | 241.7M +0.54% | 240.4M -0.08% | 240.6M -1.11% | 243.3M -0.29% | |
Diluted Weighted Average Shares | 241.7M +0.54% | 240.4M -0.08% | 240.6M -1.11% | 243.3M -0.29% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 7.7B -21.37% | 9.8B -16.31% | 11.7B -15.94% | 13.9B +719.70% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 7.7B -21.37% | 9.8B -16.31% | 11.7B -15.94% | 13.9B +719.70% | |
Total Current Assets | 16.1B -14.13% | 18.8B -3.71% | 19.5B -10.92% | 21.9B +45.45% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 1.1B +15.57% | 935.3M +23.52% | 757.2M +24.29% | 609.2M +88.90% | |
Total Long-Term Assets | 5.8B +56.78% | 3.7B +7.11% | 3.5B +156.36% | 1.4B +78.92% | |
Total Assets | 22.0B -2.40% | 22.5B -2.07% | 23.0B -1.17% | 23.3B +47.05% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 2.1B -15.10% | 2.5B +21.86% | 2.1B -29.83% | 3.0B -15.25% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 622.1M +4.48% | 595.4M -13.70% | 689.9M +152.80% | 272.9M -40.09% | |
Total Liabilities | 2.8B -11.36% | 3.1B +12.98% | 2.8B -14.37% | 3.2B -18.13% | |
Retained Earnings | 18.0B -5.95% | 19.1B -3.37% | 19.8B +4.94% | 18.8B +90.56% | |
Total Stockholders Equity | 19.2B -0.96% | 19.4B -4.12% | 20.2B +0.95% | 20.1B +68.62% | |
Total Shares Outstanding | 251.3M +4.73% | 240.0M +0.94% | 237.7M -2.26% | 243.2M N/A | |
Cash Flow | |||||
Cash from Operating Activities | 456.0M +119.55% | 207.7M -96.13% | 5.4B -60.44% | 13.6B +1,426.06% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -2.5B +18.61% | -2.1B -70.07% | -7.0B +19,601.13% | -35.3M -93.76% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -52.9M +15.25% | -45.9M -94.10% | -778.6M -45.14% | -1.4B -1,606.69% | |
Financials Ratio | |||||
Gross Margin | -969.67% -1,307.19% | 80.32% -4.71% | 84.29% +1.93% | 82.70% -2.31% | |
Operating Margin | -2,341.50% +4,801.24% | -47.77% -364.26% | 18.08% -75.25% | 73.03% -9.32% | |
Return on Assets | -5.10% +74.67% | -2.92% -172.69% | 4.02% -91.67% | 48.25% -57.46% | |
Return on Equity | -5.88% +75.28% | -3.36% -172.68% | 4.62% -92.18% | 59.06% -61.94% | |
Revenue Growth | -97.82% +249.82% | -27.96% -64.12% | -77.94% +787.71% | -8.78% -100.23% | |
Current Ratio | 7.54 +1.14% | 7.45 -20.98% | 9.43 +26.94% | 7.43 +71.62% | |
Cash Ratio | 3.58 -7.39% | 3.87 -31.32% | 5.63 +19.79% | 4.70 +867.19% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow